Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 123 articles:
HTML format
Text format



Single Articles


    March 2017
  1. LIU Y, Sun Y, Zhao A
    MicroRNA-134 suppresses cell proliferation in gastric cancer cells via targeting of GOLPH3.
    Oncol Rep. 2017 Mar 2. doi: 10.3892/or.2017.5488.
    PubMed     Text format     Abstract available


  2. SUI W, Shi Z, Xue W, Ou M, et al
    Circular RNA and gene expression profiles in gastric cancer based on microarray chip technology.
    Oncol Rep. 2017;37:1804-1814.
    PubMed     Text format     Abstract available


  3. YU J, Wang X, Li Y, Tang B, et al
    Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1.
    Oncol Rep. 2017;37:1394-1400.
    PubMed     Text format     Abstract available


    February 2017
  4. TAMAKI R, Kanai-Mori A, Morishige Y, Koike A, et al
    Effects of 5-fluorouracil, adriamycin and irinotecan on HSC-39, a human scirrhous gastric cancer cell line.
    Oncol Rep. 2017 Feb 20. doi: 10.3892/or.2017.5470.
    PubMed     Text format     Abstract available


  5. WANG J, Zhou Y, Fei X, Chen X, et al
    ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126.
    Oncol Rep. 2017 Feb 16. doi: 10.3892/or.2017.5460.
    PubMed     Text format     Abstract available


  6. SUN DP, Fang CL, Chen HK, Wen KS, et al
    EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5442.
    PubMed     Text format     Abstract available


  7. WANG L, Huang X, Chai Y, Zou L, et al
    Octreotide inhibits the proliferation of gastric cancer cells through P300-HAT activity and the interaction of ZAC and P300.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5451.
    PubMed     Text format     Abstract available


  8. HUANG Y, Li X, Sha H, Zhang L, et al
    Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy.
    Oncol Rep. 2017 Feb 10. doi: 10.3892/or.2017.5440.
    PubMed     Text format     Abstract available


    January 2017
  9. XIE R, Wang H, Jin H, Wen G, et al
    NHE1 is upregulated in gastric cancer and regulates gastric cancer cell proliferation, migration and invasion.
    Oncol Rep. 2017 Jan 18. doi: 10.3892/or.2017.5386.
    PubMed     Text format     Abstract available


  10. CAO W, Wei W, Zhan Z, Xie D, et al
    Role of miR-647 in human gastric cancer suppression.
    Oncol Rep. 2017 Jan 17. doi: 10.3892/or.2017.5383.
    PubMed     Text format     Abstract available


  11. LI C, Lu S, Shi Y
    MicroRNA-187 promotes growth and metastasis of gastric cancer by inhibiting FOXA2.
    Oncol Rep. 2017 Jan 16. doi: 10.3892/or.2017.5370.
    PubMed     Text format     Abstract available


  12. LI A, Li J, Lin J, Zhuo W, et al
    COL11A1 is overexpressed in gastric cancer tissues and regulates proliferation, migration and invasion of HGC-27 gastric cancer cells in vitro.
    Oncol Rep. 2017;37:333-340.
    PubMed     Text format     Abstract available


    November 2016
  13. LI W, Wang Z, Zha L, Kong D, et al
    HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer.
    Oncol Rep. 2016 Nov 18. doi: 10.3892/or.2016.5255.
    PubMed     Text format     Abstract available


  14. YANG C, Gao J, Yan N, Wu B, et al
    Propofol inhibits the growth and survival of gastric cancer cells in vitro through the upregulation of ING3.
    Oncol Rep. 2016 Nov 4. doi: 10.3892/or.2016.5218.
    PubMed     Text format     Abstract available


  15. LU X, Ma J, Qiu H, Yang L, et al
    Anti-proliferation effects of trifolirhizin on MKN45 cells and possible mechanism.
    Oncol Rep. 2016;36:2785-2792.
    PubMed     Text format     Abstract available


    October 2016
  16. ZHANG J, Zhu JS, Zhou Z, Chen WX, et al
    [Retracted] Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo.
    Oncol Rep. 2016 Oct 19. doi: 10.3892/or.2016.5181.
    PubMed     Text format     Abstract available


  17. CHEN B, Zhao J, Zhang S, Zhang Y, et al
    HPIP promotes gastric cancer cell proliferation through activation of cap-dependent translation.
    Oncol Rep. 2016 Oct 11. doi: 10.3892/or.2016.5157.
    PubMed     Text format     Abstract available


  18. FENG S, Zheng Z, Feng L, Yang L, et al
    Proton pump inhibitor pantoprazole inhibits the proliferation, selfrenewal and chemoresistance of gastric cancer stem cells via the EMT/betacatenin pathways.
    Oncol Rep. 2016 Oct 7. doi: 10.3892/or.2016.5154.
    PubMed     Text format     Abstract available


  19. CHEN SY, Zhang RG, Duan GC
    Pathogenic mechanisms of the oncoprotein CagA in H. pylori-induced gastric cancer (Review).
    Oncol Rep. 2016 Oct 4. doi: 10.3892/or.2016.5145.
    PubMed     Text format     Abstract available


    September 2016
  20. HUANG T, Zhou F, Wang-Johanning F, Nan K, et al
    Depression accelerates the development of gastric cancer through reactive oxygen speciesactivated ABL1 (Review).
    Oncol Rep. 2016 Sep 23. doi: 10.3892/or.2016.5127.
    PubMed     Text format     Abstract available


  21. XU H, Peng JG, Zhuang YF, Chen JJ, et al
    Establishment and characterization of an expanding-type gastric cancer cell line by Ming's classification.
    Oncol Rep. 2016 Sep 14. doi: 10.3892/or.2016.5090.
    PubMed     Text format     Abstract available


  22. LI J, Gao X, Ji K, Sanders AJ, et al
    Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression.
    Oncol Rep. 2016 Sep 8. doi: 10.3892/or.2016.5074.
    PubMed     Text format     Abstract available


  23. BU X, Li M, Zhao Y, Liu S, et al
    Genetically engineered Newcastle disease virus expressing human interferon-lambda1 induces apoptosis in gastric adenocarcinoma cells and modulates the Th1/Th2 immune response.
    Oncol Rep. 2016;36:1393-402.
    PubMed     Text format     Abstract available


    August 2016
  24. OKUGAWA Y, Mohri Y, Tanaka K, Kawamura M, et al
    Metastasis-associated protein is a predictive biomarker for metastasis and recurrence in gastric cancer.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5054.
    PubMed     Text format     Abstract available


  25. WANG W, Liu J, Qi J, Zhang J, et al
    RLIP76 increases apoptosis through Akt/mTOR signaling pathway in gastric cancer.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5043.
    PubMed     Text format     Abstract available


  26. XIONG J, Li Z, Zhang Y, Li D, et al
    PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
    Oncol Rep. 2016 Aug 23. doi: 10.3892/or.2016.5030.
    PubMed     Text format     Abstract available


  27. WANG H, Xiong M, Hu Y, Sun Y, et al
    MicroRNA-19b inhibits proliferation of gastric cancer cells by targeting B-cell CLL/lymphoma 3.
    Oncol Rep. 2016 Aug 23. doi: 10.3892/or.2016.5029.
    PubMed     Text format     Abstract available


  28. ZHANG Z, Kong Y, Yang W, Ma F, et al
    Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
    Oncol Rep. 2016 Aug 11. doi: 10.3892/or.2016.5016.
    PubMed     Text format     Abstract available


  29. DONG S, Xia J, Wang H, Sun L, et al
    Overexpression of TRIB3 promotes angiogenesis in human gastric cancer.
    Oncol Rep. 2016 Aug 11. doi: 10.3892/or.2016.5017.
    PubMed     Text format     Abstract available


  30. LI Y, Nie Y, Tu S, Wang H, et al
    Epigenetically deregulated miR-200c is involved in a negative feedback loop with DNMT3a in gastric cancer cells.
    Oncol Rep. 2016 Aug 2. doi: 10.3892/or.2016.4996.
    PubMed     Text format     Abstract available


  31. KONG Y, Zheng Y, Jia Y, Li P, et al
    Decreased LIPF expression is correlated with DGKA and predicts poor outcome of gastric cancer.
    Oncol Rep. 2016 Aug 1. doi: 10.3892/or.2016.4989.
    PubMed     Text format     Abstract available


    July 2016
  32. JIANG Z, Liu Z, Zou S, Ni J, et al
    Transcription factor c-jun regulates beta3Gn-T8 expression in gastric cancer cell line SGC-7901.
    Oncol Rep. 2016 Jul 21. doi: 10.3892/or.2016.4959.
    PubMed     Text format     Abstract available


  33. YANG C, Zheng W, Du W
    CXCR3A contributes to the invasion and metastasis of gastric cancer cells.
    Oncol Rep. 2016 Jul 19. doi: 10.3892/or.2016.4953.
    PubMed     Text format     Abstract available


  34. ZHUANG K, Yan Y, Zhang X, Zhang J, et al
    Gastrin promotes the metastasis of gastric carcinoma through the beta-catenin/TCF-4 pathway.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4943.
    PubMed     Text format     Abstract available


    June 2016
  35. XIE M, Dart DA, Owen S, Wen X, et al
    Insights into roles of the miR-1, -133 and -206 family in gastric cancer (Review).
    Oncol Rep. 2016 Jun 27. doi: 10.3892/or.2016.4908.
    PubMed     Text format     Abstract available


  36. YANG M, Qu Y, Shi R, Wu X, et al
    Ubiquitin-conjugating enzyme UbcH10 promotes gastric cancer growth and is a potential biomarker for gastric cancer.
    Oncol Rep. 2016 Jun 23. doi: 10.3892/or.2016.4906.
    PubMed     Text format     Abstract available


  37. YIN G, Zhou H, Xue Y, Yao B, et al
    MicroRNA-340 promotes the tumor growth of human gastric cancer by inhibiting cyclin G2.
    Oncol Rep. 2016 Jun 15. doi: 10.3892/or.2016.4876.
    PubMed     Text format     Abstract available


  38. SU CC, Chiu TL
    Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivo.
    Oncol Rep. 2016 Jun 7. doi: 10.3892/or.2016.4857.
    PubMed     Text format     Abstract available


  39. CAO X, Ren K, Song Z, Li D, et al
    7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells.
    Oncol Rep. 2016 Jun 2. doi: 10.3892/or.2016.4848.
    PubMed     Text format     Abstract available


  40. YANG R, Zeng Y, Xu H, Chen Z, et al
    Heterogeneous nuclear ribonucleoprotein K is overexpressed and associated with poor prognosis in gastric cancer.
    Oncol Rep. 2016 Jun 2. doi: 10.3892/or.2016.4845.
    PubMed     Text format     Abstract available


  41. OHNO T, Ohtani M, Suto H, Ohta M, et al
    Effect of green tea catechins on gastric mucosal dysplasia in insulin-gastrin mice.
    Oncol Rep. 2016;35:3241-7.
    PubMed     Text format     Abstract available


    May 2016
  42. SU C, Zhang B, Liu W, Zheng H, et al
    High extracellular pressure promotes gastric cancer cell adhesion, invasion, migration and suppresses gastric cancer cell differentiation.
    Oncol Rep. 2016 May 30. doi: 10.3892/or.2016.4841.
    PubMed     Text format     Abstract available


  43. LI PY, Lv J, Qi WW, Zhao SF, et al
    Tspan9 inhibits the proliferation, migration and invasion of human gastric cancer SGC7901 cells via the ERK1/2 pathway.
    Oncol Rep. 2016 May 13. doi: 10.3892/or.2016.4805.
    PubMed     Text format     Abstract available


    April 2016
  44. OUE N, Mukai S, Imai T, Pham TT, et al
    Induction of KIFC1 expression in gastric cancer spheroids.
    Oncol Rep. 2016 Apr 28. doi: 10.3892/or.2016.4781.
    PubMed     Text format     Abstract available


  45. LAN WG, Xu DH, Xu C, Ding CL, et al
    Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
    Oncol Rep. 2016 Apr 26. doi: 10.3892/or.2016.4771.
    PubMed     Text format     Abstract available


  46. CHANG S, Liu J, Guo S, He S, et al
    HOTTIP and HOXA13 are oncogenes associated with gastric cancer progression.
    Oncol Rep. 2016 Apr 13. doi: 10.3892/or.2016.4743.
    PubMed     Text format     Abstract available


  47. ZHANG J, Liu Y, Zhang J, Cui X, et al
    FOXQ1 promotes gastric cancer metastasis through upregulation of Snail.
    Oncol Rep. 2016 Apr 8. doi: 10.3892/or.2016.4736.
    PubMed     Text format     Abstract available


  48. PENG Y, Zhao Q, Zhang H, Han B, et al
    TIPE2, a negative regulator of TLR signaling, regulates p27 through IRF4-induced signaling.
    Oncol Rep. 2016;35:2480-6.
    PubMed     Text format     Abstract available


    March 2016
  49. XU JM, Zhou Y, Gao L, Zhou SX, et al
    Stromal interaction molecule 1 plays an important role in gastric cancer progression.
    Oncol Rep. 2016 Mar 24. doi: 10.3892/or.2016.4704.
    PubMed     Text format     Abstract available


  50. XU Y, Jin X, Huang Y, Dong J, et al
    Inhibition of peritoneal metastasis of human gastric cancer cells by dextran sulphate through the reduction in HIF-1alpha and ITGbeta1 expression.
    Oncol Rep. 2016 Mar 18. doi: 10.3892/or.2016.4693.
    PubMed     Text format     Abstract available


  51. LIN X, Huang Y, Zou Y, Chen X, et al
    Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
    Oncol Rep. 2016 Mar 17. doi: 10.3892/or.2016.4692.
    PubMed     Text format     Abstract available


  52. LU S, Ma Y, Sun T, Ren R, et al
    Expression of alpha-fetoprotein in gastric cancer AGS cells contributes to invasion and metastasis by influencing anoikis sensitivity.
    Oncol Rep. 2016 Mar 16. doi: 10.3892/or.2016.4678.
    PubMed     Text format     Abstract available


  53. LI L, Wen XZ, Bu ZD, Cheng XJ, et al
    Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells.
    Oncol Rep. 2016 Mar 9. doi: 10.3892/or.2016.4666.
    PubMed     Text format     Abstract available


  54. WU Y, Zhang Q, Ruan Z, Yin Y, et al
    Intrinsic effects of gold nanoparticles on proliferation and invasion activity in SGC-7901 cells.
    Oncol Rep. 2016;35:1457-62.
    PubMed     Text format     Abstract available


    February 2016
  55. CAO W, Wei W, Zhan Z, Xie Y, et al
    miR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1.
    Oncol Rep. 2016 Feb 29. doi: 10.3892/or.2016.4643.
    PubMed     Text format     Abstract available


  56. LIU K, Qin YH, Yu JY, Ma H, et al
    3-beta-Epsilonrythrodiol isolated from Conyza canadensis inhibits MKN45 human gastric cancer cell proliferation by inducing apoptosis, cell cycle arrest, DNA fragmentation, ROS generation and reduces tumor weight and volume in mouse xenograft model.
    Oncol Rep. 2016 Feb 3. doi: 10.3892/or.2016.4610.
    PubMed     Text format     Abstract available


  57. ZHANG H, Qu Y, Duan J, Deng T, et al
    Integrated analysis of the miRNA, gene and pathway regulatory network in gastric cancer.
    Oncol Rep. 2016;35:1135-1146.
    PubMed     Text format     Abstract available


  58. GAO L, Xu Z, Wang Y, Sun B, et al
    Anticancer effect of SZC017, a novel derivative of oleanolic acid, on human gastric cancer cells.
    Oncol Rep. 2016;35:1101-1108.
    PubMed     Text format     Abstract available


  59. TAKANO J, Morishita A, Fujihara S, Iwama H, et al
    Galectin-9 suppresses the proliferation of gastric cancer cells in vitro.
    Oncol Rep. 2016;35:851-860.
    PubMed     Text format     Abstract available


    January 2016
  60. GENG Y, Lu X, Wu X, Xue L, et al
    MicroRNA-27b suppresses Helicobacter pylori-induced gastric tumorigenesis through negatively regulating Frizzled7.
    Oncol Rep. 2016 Jan 18. doi: 10.3892/or.2016.4572.
    PubMed     Text format     Abstract available


  61. ZHAO G, Zhu G, Huang Y, Zheng W, et al
    IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
    Oncol Rep. 2016 Jan 5. doi: 10.3892/or.2016.4544.
    PubMed     Text format     Abstract available


    December 2015
  62. LI C, Liang G, Yao W, Sui J, et al
    Differential expression profiles of long non-coding RNAs reveal potential biomarkers for identification of human gastric cancer.
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4531.
    PubMed     Text format     Abstract available


  63. YUAN DD, Zhu ZX, Zhang X, Liu J, et al
    Targeted therapy for gastric cancer: Current status and future directions (Review).
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4528.
    PubMed     Text format     Abstract available


  64. WANG TA, Zhang XD, Guo XY, Xian SL, et al
    3-Bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial-mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth.
    Oncol Rep. 2015 Dec 23. doi: 10.3892/or.2015.4511.
    PubMed     Text format     Abstract available


  65. RIBEIRO CH, Kramm K, Galvez-Jiron F, Pola V, et al
    Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients.
    Oncol Rep. 2015 Dec 23. doi: 10.3892/or.2015.4510.
    PubMed     Text format     Abstract available


  66. HAYASHI N, Ando Y, Gyawali B, Shimokata T, et al
    Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer.
    Oncol Rep. 2015 Dec 8. doi: 10.3892/or.2015.4475.
    PubMed     Text format     Abstract available


    November 2015
  67. NIE C, Zhou J, Qin X, Shi X, et al
    Reduction of apoptosis by proanthocyanidin-induced autophagy in the human gastric cancer cell line MGC-803.
    Oncol Rep. 2015 Nov 13. doi: 10.3892/or.2015.4419.
    PubMed     Text format     Abstract available


  68. JING X, Cheng W, Wang S, Li P, et al
    Resveratrol induces cell cycle arrest in human gastric cancer MGC803 cells via the PTENregulated PI3K/Akt signaling pathway.
    Oncol Rep. 2015 Nov 3. doi: 10.3892/or.2015.4384.
    PubMed     Text format     Abstract available


    September 2015
  69. WU J, Zhang XX, Sun QM, Chen M, et al
    beta-asarone inhibits gastric cancer cell proliferation.
    Oncol Rep. 2015 Sep 30. doi: 10.3892/or.2015.4316.
    PubMed     Text format     Abstract available


  70. WEN T, Hou K, Li Z, Li L, et al
    Silencing beta-linked N-acetylglucosamine transferase induces apoptosis in human gastric cancer cells through PUMA and caspase-3 pathways.
    Oncol Rep. 2015 Sep 15. doi: 10.3892/or.2015.4276.
    PubMed     Text format     Abstract available


  71. ZHONG F, Cui D, Tao H, Du H, et al
    IL-17A-producing T cells and associated cytokines are involved in the progression of gastric cancer.
    Oncol Rep. 2015 Sep 7. doi: 10.3892/or.2015.4246.
    PubMed     Text format     Abstract available


  72. WANG RX, Liu H, Xu L, Zhang H, et al
    Involvement of nuclear receptor RZR/RORgamma in melatonin-induced HIF-1alpha inactivation in SGC-7901 human gastric cancer cells.
    Oncol Rep. 2015 Sep 1. doi: 10.3892/or.2015.4238.
    PubMed     Text format     Abstract available


  73. YANG Y, Li M, Yan Y, Zhang J, et al
    Expression of RAP1B is associated with poor prognosis and promotes an aggressive phenotype in gastric cancer.
    Oncol Rep. 2015 Sep 1. doi: 10.3892/or.2015.4234.
    PubMed     Text format     Abstract available


  74. ZHU GC, Gao L, He J, Long Y, et al
    CD90 is upregulated in gastric cancer tissues and inhibits gastric cancer cell apoptosis by modulating the expression level of SPARC protein.
    Oncol Rep. 2015 Sep 1. doi: 10.3892/or.2015.4243.
    PubMed     Text format     Abstract available


    August 2015
  75. LI TF, Qin SH, Ruan XZ, Wang X, et al
    p120-catenin participates in the progress of gastric cancer through regulating the Rac1 and Pak1 signaling pathway.
    Oncol Rep. 2015 Aug 26. doi: 10.3892/or.2015.4226.
    PubMed     Text format     Abstract available


  76. LIU H, Liang S, Yang X, Ji Z, et al
    RNAi-mediated RPL34 knockdown suppresses the growth of human gastric cancer cells.
    Oncol Rep. 2015 Aug 21. doi: 10.3892/or.2015.4219.
    PubMed     Text format     Abstract available


  77. JUN KH, Lee JE, Kim SH, Jung JH, et al
    Clinicopathological significance of N-cadherin and VEGF in advanced gastric cancer brain metastasis and the effects of metformin in preclinical models.
    Oncol Rep. 2015 Aug 10. doi: 10.3892/or.2015.4191.
    PubMed     Text format     Abstract available


  78. GHONEUM M, Felo N
    Selective induction of apoptosis in human gastric cancer cells by Lactobacillus kefiri (PFT), a novel kefir product.
    Oncol Rep. 2015 Aug 6. doi: 10.3892/or.2015.4180.
    PubMed     Text format     Abstract available


    July 2015
  79. GAO XY, Li L, Wang XH, Wen XZ, et al
    Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.
    Oncol Rep. 2015 Jul 30. doi: 10.3892/or.2015.4162.
    PubMed     Text format     Abstract available


  80. DING J, Feng M, Wang F, Wang H, et al
    Targeting effect of PEGylated liposomes modi fi ed with the Arg-Gly-Asp sequence on gastric cancer.
    Oncol Rep. 2015 Jul 22. doi: 10.3892/or.2015.4142.
    PubMed     Text format     Abstract available


  81. ZHAO Z, Song Y, Piao D, Liu T, et al
    Identification of genes and long non-coding RNAs associated with the pathogenesis of gastric cancer.
    Oncol Rep. 2015 Jul 14. doi: 10.3892/or.2015.4129.
    PubMed     Text format     Abstract available


  82. JIANG H, Yu WW, Wang LL, Peng Y, et al
    miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3.
    Oncol Rep. 2015 Jul 1. doi: 10.3892/or.2015.4099.
    PubMed     Text format     Abstract available


    June 2015
  83. YUN M, Rong J, Lin ZR, He YL, et al
    High expression of transforming acidic coiled coil-containing protein 3 strongly correlates with aggressive characteristics and poor prognosis of gastric cancer.
    Oncol Rep. 2015 Jun 30. doi: 10.3892/or.2015.4093.
    PubMed     Text format     Abstract available


  84. LIM SC, Han SI
    Ursodeoxycholic acid effectively kills drug-resistant gastric cancer cells through induction of autophagic death.
    Oncol Rep. 2015 Jun 24. doi: 10.3892/or.2015.4076.
    PubMed     Text format     Abstract available


  85. OKITA Y, Ohira M, Tanaka H, Tokumoto M, et al
    Alteration of CD4 T cell subsets in metastatic lymph nodes of human gastric cancer.
    Oncol Rep. 2015 Jun 15. doi: 10.3892/or.2015.4064.
    PubMed     Text format     Abstract available


  86. LEE WS, Kim N, Park YR, Oh HH, et al
    Myeloid cell leukemia-1 promotes epithelial-mesenchymal transition of human gastric cancer cells.
    Oncol Rep. 2015 Jun 8. doi: 10.3892/or.2015.4040.
    PubMed     Text format     Abstract available


  87. BAE JH, Kang MJ, Yang KM, Kim TO, et al
    Epigenetically silenced microRNAs in gastric cancer: Functional analysis and identification of their target genes.
    Oncol Rep. 2015 Jun 5. doi: 10.3892/or.2015.4036.
    PubMed     Text format     Abstract available


  88. HABIB R, Akhtar J, Taqi M, Yu C, et al
    Lentiviral vector-mediated survivin shRNA delivery in gastric cancer cell lines significantly inhibits cell proliferation and tumor growth.
    Oncol Rep. 2015 Jun 5. doi: 10.3892/or.2015.4033.
    PubMed     Text format     Abstract available


  89. LIU SQ, Xu CY, Qin MB, Tan L, et al
    Ginkgo biloba extract enhances chemotherapy sensitivity and reverses chemoresistance through suppression of the KSR1-mediated ERK1/2 pathway in gastric cancer cells.
    Oncol Rep. 2015;33:2871-82.
    PubMed     Text format     Abstract available


  90. CHEN J, Sun D, Chu H, Gong Z, et al
    Screening of differential microRNA expression in gastric signet ring cell carcinoma and gastric adenocarcinoma and target gene prediction.
    Oncol Rep. 2015;33:2963-71.
    PubMed     Text format     Abstract available


    May 2015
  91. LIN L, Jiang H, Huang M, Hou X, et al
    Depletion of histone deacetylase 1 inhibits metastatic abilities of gastric cancer cells by regulating the miR-34a/CD44 pathway.
    Oncol Rep. 2015 May 28. doi: 10.3892/or.2015.4010.
    PubMed     Text format     Abstract available


  92. HUAN Y, Wu D, Zhou D, Sun B, et al
    DBC1 promotes anoikis resistance of gastric cancer cells by regulating NF-kappaB activity.
    Oncol Rep. 2015 May 28. doi: 10.3892/or.2015.4007.
    PubMed     Text format     Abstract available


  93. WU F, Lv T, Chen G, Ye H, et al
    Epigenetic silencing of DUSP9 induces the proliferation of human gastric cancer by activating JNK signaling.
    Oncol Rep. 2015 May 20. doi: 10.3892/or.2015.3998.
    PubMed     Text format     Abstract available


  94. SUN T, Jia Y, Xiao D
    Interference of STAT 5b expression enhances the chemo-sensitivity of gastric cancer cells to gefitinib by promoting mitochondrial pathway-mediated cell apoptosis.
    Oncol Rep. 2015 May 19. doi: 10.3892/or.2015.3994.
    PubMed     Text format     Abstract available


  95. KIM SH, Kang YJ, Sung B, Kim DH, et al
    MHY-449, a novel dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivative, mediates oxidative stress-induced apoptosis in AGS human gastric cancer cells.
    Oncol Rep. 2015 May 18. doi: 10.3892/or.2015.3984.
    PubMed     Text format     Abstract available


  96. ZHANG X, Zheng L, Sun Y, Wang T, et al
    Tangeretin enhances radiosensitivity and inhibits the radiation-induced epithelial-mesenchymal transition of gastric cancer cells.
    Oncol Rep. 2015 May 15. doi: 10.3892/or.2015.3982.
    PubMed     Text format     Abstract available


  97. WEN X, Wu JQ, Peng W, Feng JF, et al
    MicroRNA-377 predicts poor clinical outcome of gastric cancer and induces tumorigenesis by targeting multiple tumor-suppressor genes.
    Oncol Rep. 2015 May 15. doi: 10.3892/or.2015.3981.
    PubMed     Text format     Abstract available


  98. HARA K, Fukui H, Sun C, Kitayama Y, et al
    Effect of REG Ialpha protein on angiogenesis in gastric cancer tissues.
    Oncol Rep. 2015;33:2183-9.
    PubMed     Text format     Abstract available


  99. SU B, Su J, He H, Wu Y, et al
    Identification of potential targets for diallyl disulfide in human gastric cancer MGC-803 cells using proteomics approaches.
    Oncol Rep. 2015;33:2484-94.
    PubMed     Text format     Abstract available


    April 2015
  100. CHEN P, Zhao D, Wang W, Zhang Y, et al
    High expression of RELM-alpha correlates with poor prognosis and promotes angiogenesis in gastric cancer.
    Oncol Rep. 2015 Apr 30. doi: 10.3892/or.2015.3943.
    PubMed     Text format     Abstract available


  101. SHI J, Li YJ, Yan B, Wei PK, et al
    Interleukin-8: A potent promoter of human lymphatic endothelial cell growth in gastric cancer.
    Oncol Rep. 2015 Apr 17. doi: 10.3892/or.2015.3916.
    PubMed     Text format     Abstract available


  102. WANG X, Zhou P, Sun X, Zheng J, et al
    Acidified bile acids increase hTERT expression via c-myc activation in human gastric cancer cells.
    Oncol Rep. 2015 Apr 9. doi: 10.3892/or.2015.3908.
    PubMed     Text format     Abstract available


  103. YE XL, Zhao YR, Weng GB, Chen YC, et al
    IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance.
    Oncol Rep. 2015 Apr 3. doi: 10.3892/or.2015.3898.
    PubMed     Text format     Abstract available


    March 2015
  104. ZHANG Y, Han T, Wei G, Wang Y, et al
    Inhibition of microRNA-17/20a suppresses cell proliferation in gastric cancer by modulating UBE2C expression.
    Oncol Rep. 2015 Mar 5. doi: 10.3892/or.2015.3835.
    PubMed     Text format     Abstract available


    February 2015
  105. ZHU X, Liu J, Xu X, Zhang C, et al
    Genomewide analysis of histone modifications by ChIPchip to identify silenced genes in gastric cancer.
    Oncol Rep. 2015 Feb 27. doi: 10.3892/or.2015.3824.
    PubMed     Text format     Abstract available


  106. TANG L, Chen F, Pang EJ, Zhang ZQ, et al
    MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer.
    Oncol Rep. 2015 Feb 12. doi: 10.3892/or.2015.3798.
    PubMed     Text format     Abstract available


  107. DING Q, Zhang M, Liu C
    Asporin participates in gastric cancer cell growth and migration by influencing EGF receptor signaling.
    Oncol Rep. 2015 Feb 9. doi: 10.3892/or.2015.3791.
    PubMed     Text format     Abstract available


  108. ZHANG QY, Wu LQ, Zhang T, Han YF, et al
    Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1/2.
    Oncol Rep. 2015 Feb 4. doi: 10.3892/or.2015.3782.
    PubMed     Text format     Abstract available


    January 2015
  109. YUAN F, Shi H, Ji J, Cai Q, et al
    Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis.
    Oncol Rep. 2015 Jan 29. doi: 10.3892/or.2015.3765.
    PubMed     Text format     Abstract available


  110. JIN H, Park MH, Kim SM
    3,3'-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade.
    Oncol Rep. 2015 Jan 28. doi: 10.3892/or.2015.3758.
    PubMed     Text format     Abstract available


  111. YANG X, Cai H, Liang Y, Chen L, et al
    Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
    Oncol Rep. 2015 Jan 28. doi: 10.3892/or.2015.3757.
    PubMed     Text format     Abstract available


  112. YANG GL, Tao HR, Wang HW, Sun Y, et al
    Ara-C increases gastric cancer cell invasion by upregulating CD-147-MMP-2/MMP9 via the ERK signaling pathway.
    Oncol Rep. 2015 Jan 23. doi: 10.3892/or.2015.3748.
    PubMed     Text format     Abstract available


    December 2014
  113. ZHANG G, Wang Z, Qian F, Zhao C, et al
    Silencing of the ABCC4 gene by RNA interference reverses multidrug resistance in human gastric cancer.
    Oncol Rep. 2014 Dec 30. doi: 10.3892/or.2014.3702.
    PubMed     Text format     Abstract available


  114. SONG H, Xu W, Song J, Liang Y, et al
    Overexpression of Lin28 inhibits the proliferation, migration and cell cycle progression and induces apoptosis of BGC-823 gastric cancer cells.
    Oncol Rep. 2014 Dec 15. doi: 10.3892/or.2014.3674.
    PubMed     Text format     Abstract available


  115. YAN X, Rui X, Zhang K
    Baicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathway.
    Oncol Rep. 2014 Dec 11. doi: 10.3892/or.2014.3669.
    PubMed     Text format     Abstract available


  116. SONG H, Bao J, Wei Y, Chen Y, et al
    Kaempferol inhibits gastric cancer tumor growth: An in vitro and in vivo study.
    Oncol Rep. 2014 Dec 9. doi: 10.3892/or.2014.3662.
    PubMed     Text format     Abstract available


  117. WEI LM, Cao S, Yu WD, Liu YL, et al
    Overexpression of CX3CR1 is associated with cellular metastasis, proliferation and survival in gastric cancer.
    Oncol Rep. 2014 Dec 4. doi: 10.3892/or.2014.3645.
    PubMed     Text format     Abstract available


    November 2014
  118. SHINBO T, Fushida S, Tsukada T, Harada S, et al
    Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-beta signaling pathway.
    Oncol Rep. 2014 Nov 28. doi: 10.3892/or.2014.3636.
    PubMed     Text format     Abstract available


  119. LIU X, Yang Z, Chen Z, Chen R, et al
    Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells.
    Oncol Rep. 2014 Nov 12. doi: 10.3892/or.2014.3600.
    PubMed     Text format     Abstract available


  120. TSAI KW, Hu LY, Chen TW, Li SC, et al
    Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer.
    Oncol Rep. 2014 Nov 11. doi: 10.3892/or.2014.3598.
    PubMed     Text format     Abstract available


    June 2014
  121. KANG W, Tong JH, Chan AW, Zhao J, et al
    Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma.
    Oncol Rep. 2014;31:2579-86.
    PubMed     Text format     Abstract available


    May 2014
  122. KANG W, Tong JH, Chan AW, Cheng AS, et al
    MCM7 serves as a prognostic marker in diffuse-type gastric adenocarcinoma and siRNA-mediated knockdown suppresses its oncogenic function.
    Oncol Rep. 2014;31:2071-8.
    PubMed     Text format     Abstract available


  123. DING YP, Yang XD, Wu Y, Xing CG, et al
    Autophagy promotes the survival and development of tumors by participating in the formation of vasculogenic mimicry.
    Oncol Rep. 2014;31:2321-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: